Articles by Charles E. DiLiberti - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Charles E. DiLiberti

Final Word: The US is Falling Behind on Generic Biopharmaceuticals

It's not a question of science, but one of regulatory resolve
Jun 1, 2006

Without generic competition, the US is at risk of losing its position of leadership in biopharmaceuticals.

The Best Targets for Biogenerics

Apr 1, 2006

Of all the protein products on the US market, at most 75 are likely to become genericized.

ADVERTISEMENT

ADVERTISEMENT

Click here